Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

The Treatment of Painful Diabetic Neuropathy With Diet, a Randomized-controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this clinical trial is to determine whether targeted nutritional changes can improve symptoms of painful diabetic neuropathy. Impaired blood flow to peripheral nerves-resulting in reduced oxygen delivery and subsequent nerve injury-is a well-established contributor to neuropathy. Prior studies have shown that a whole-food, plant-based diet without added oils can improve or even reverse arterial disease, suggesting a potential mechanism for enhancing nerve perfusion and function. This study is a randomized controlled trial comparing a whole-food, plant-based diet with standard pharmacologic management for painful diabetic neuropathy.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Definitive diagnosis of type II diabetes mellitus (HgA1c ≥ 6.5) or pre-diabetes (HgA1c 5.7-6.4)

• objective documentation of peripheral neuropathy on EMG/NCS testing defined as a sural-to-radial amplitude ratio of 0.21 or less

• presence of painful neuropathy in addition to decreased sensation

• with pain rated ≥4/10 on a 0-10 numerical rating scale (NRS)

• age 18 years or older

• ability to provide informed consent

• ability to attend follow-up visits.

Locations
United States
North Carolina
AdventHealth Hendersonville
RECRUITING
Hendersonville
Contact Information
Primary
William J Beckworth, MD
william.beckworth.md@adventhealth.com
828-654-8546
Backup
Mary Stanford, Clinical Research Coordinator
mary.stanford@adventhealth.com
828-654-8546
Time Frame
Start Date: 2024-04-23
Estimated Completion Date: 2028-02-28
Participants
Target number of participants: 40
Treatments
Experimental: Diet arm
This is a whole food plant-based diet that excludes meat, dairy, eggs and oil
Experimental: medical managment
This approach reflects standard pharmacologic management of diabetic peripheral neuropathy. Commonly used medications include antiepileptic agents (gabapentin, pregabalin), serotonin-norepinephrine reuptake inhibitors (e.g., duloxetine), tricyclic antidepressants (e.g., amitriptyline, nortriptyline), and over-the-counter options such as alpha-lipoic acid and turmeric.
Sponsors
Leads: AdventHealth

This content was sourced from clinicaltrials.gov